Minxia Liu

81 Meishan Road
Hefei, 230032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

LAPTM4B Confers Resistance to EGFR-TKIs by Suppressing the Proteasomal Degradation of ATP1A1 in Non-small Cell Lung Cancer.

LAPTM4B Confers Resistance to EGFR-TKIs by Suppressing the Proteasomal Degradation of ATP1A1 in Non-small Cell Lung Cancer.

Journal: International journal of biological sciences
Published: April 08, 2025

MiR-3202-DTL signaling axis impedes NSCLC malignancy via regulating the ubiquitination-proteasome degradation of p21.

MiR-3202-DTL signaling axis impedes NSCLC malignancy via regulating the ubiquitination-proteasome degradation of p21.

Journal: Molecular and cellular biochemistry
Published: November 29, 2024

LAPTM5 Confers the Resistance to Venetoclax via Promoting the Autophagosome-Lysosome Fusion in Multiple Myeloma.

LAPTM5 Confers the Resistance to Venetoclax via Promoting the Autophagosome-Lysosome Fusion in Multiple Myeloma.

Journal: Journal of cellular and molecular medicine
Published: September 28, 2024

LAPTM4B counteracts ferroptosis via suppressing the ubiquitin-proteasome degradation of SLC7A11 in non-small cell lung cancer.

LAPTM4B counteracts ferroptosis via suppressing the ubiquitin-proteasome degradation of SLC7A11 in non-small cell lung cancer.

Journal: Cell death & disease
Published: January 16, 2024

A critical assessment of Traditional Chinese Medicine databases as a source for drug discovery.

A critical assessment of Traditional Chinese Medicine databases as a source for drug discovery.

Journal: Frontiers in pharmacology
Published: October 01, 2023

miR-137-LAPTM4B regulates cytoskeleton organization and cancer metastasis via the RhoA-LIMK-Cofilin pathway in osteosarcoma.

miR-137-LAPTM4B regulates cytoskeleton organization and cancer metastasis via the RhoA-LIMK-Cofilin pathway in osteosarcoma.

Journal: Oncogenesis
Published: November 09, 2022

LAPTM4B-35 promotes cancer cell migration via stimulating integrin beta1 recycling and focal adhesion dynamics.

LAPTM4B-35 promotes cancer cell migration via stimulating integrin beta1 recycling and focal adhesion dynamics.

Journal: Cancer science
Published: November 11, 2021

S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma.

S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma.

Journal: Frontiers in cell and developmental biology
Published: June 09, 2021

Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML.

Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML.

Journal: Leukemia
Published: March 08, 2019

New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network.

New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network.

Journal: Frontiers in molecular biosciences
Published: April 15, 2017

MicroRNA-944 Affects Cell Growth by Targeting EPHA7 in Non-Small Cell Lung Cancer.

MicroRNA-944 Affects Cell Growth by Targeting EPHA7 in Non-Small Cell Lung Cancer.

Journal: International journal of molecular sciences
Published: July 25, 2016

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML.

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML.

Journal: Blood
Published: February 24, 2016
Showing 1-12 of 14

Last Updated: 09/26/2026